|
ACIN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.178810E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.208100E-02 |
| Normal-vs-Stage2 |
3.424800E-01 |
| Normal-vs-Stage3 |
9.001000E-01 |
| Normal-vs-Stage4 |
6.401200E-01 |
| Stage1-vs-Stage2 |
7.878800E-01 |
| Stage1-vs-Stage3 |
4.137700E-02 |
| Stage1-vs-Stage4 |
4.825400E-01 |
| Stage2-vs-Stage3 |
2.830800E-01 |
| Stage2-vs-Stage4 |
7.197000E-01 |
| Stage3-vs-Stage4 |
5.948600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.209020E-01 |
| Normal-vs-AfricanAmerican |
4.045200E-01 |
| Normal-vs-Asian |
9.033600E-04 |
| Caucasian-vs-AfricanAmerican |
9.177600E-01 |
| Caucasian-vs-Asian |
1.331550E-02 |
| AfricanAmerican-vs-Asian |
6.389700E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.744390E-01 |
| Normal-vs-Female |
1.580230E-01 |
| Male-vs-Female |
7.500800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.719900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.575970E-01 |
| Normal-vs-Age(61-80Yrs) |
6.164800E-01 |
| Normal-vs-Age(81-100Yrs) |
4.480000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.143200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.712400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.990840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.422500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.515600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.196000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.58670000000227E-06 |
| Classical-VS-Follicular |
3.676900E-03 |
| Classical-VS-Other |
7.411400E-01 |
| Classical-VS-Normal |
2.600500E-03 |
| Tall-VS-Follicular |
1.430360E-01 |
| Tall-VS-Other |
1.202440E-01 |
| Tall-VS-Normal |
1.419800E-02 |
| Follicular-VS-Other |
2.504200E-01 |
| Follicular-VS-Normal |
5.128800E-01 |
| Other-VS-Normal |
3.753800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.446600E-01 |
| Normal-vs-N1 |
1.244190E-01 |
| N0-vs-N1 |
3.832400E-01 |
|
|
